SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

The FDA issued a Complete Response Letter for Summits ivonescimab application, citing the lack of a statistically significant overall-survival benefit, prompting heavy selling and debate over whether strong progression-free-survival results and later survival data could support a regulatory challenge. Some traders view the decision as a setback limited to this indication and point to HARMONi-3 as the next major test of the drugs potential.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,112,050. The last known price of Bitcoin is 63,437.21016941 USD and is down -7.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $45,086,253,428.50 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp slide from recent highs toward the low-$60,000s and subsequent rebound has sparked debate over whether the selloff is nearing a bottom or will extend lower. Traders point to liquidations and broader risk-off pressure, while claims about ETF selling, the Binance hack and macro risks remain part of the communitys discussion rather than a clearly established single cause.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,752,062,860.16806072. The last known price of Dogecoin is 0.05689686 USD and is down -11.89 over the last 24 hours. It is currently trading on 1545 active market(s) with $1,128,721,930.78 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is under pressure amid a broad crypto-market selloff, with traders focused on its steep decline, fresh multi-year lows and weak technical momentum. The community is divided between calling the drop a buying opportunity and expecting further losses or capitulation.

JasmyCoin (JASMY) is a cryptocurrency launched in 2016and operates on the Ethereum platform. JasmyCoin has a current supply of 50,000,000,000 with 49,444,999,677.16957912 in circulation. The last known price of JasmyCoin is 0.00312867 USD and is down -5.82 over the last 24 hours. It is currently trading on 374 active market(s) with $10,034,947.48 traded over the last 24 hours. More information can be found at https://www.jasmy.co.jp/en_company.html.

JasmyCoin

JASMYs weak, volatile price action is driving a split between holders buying the dip and critics frustrated by its prolonged underperformance, limited on-chain activity, and the teams focus on Janction. Bulls point to the AppBank/Money Twin collaboration and JasmyChains potential utility, but debate centers on whether those developments will translate into real adoption.

Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus is drawing attention ahead of the Phase 3 APPROACH topline readout for HLP003, its adjunctive major-depression candidate; traders are split between optimism about the trial design and concern over the binary clinical risk. Discussion also centers on dilution and management equity compensation disclosed in a recent filing, with some investors arguing funding is adequate to reach the readout.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,218,624.4003947. The last known price of Ethereum is 1,739.90377069 USD and is down -9.84 over the last 24 hours. It is currently trading on 14359 active market(s) with $18,820,901,710.98 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

A sharp Ethereum decline alongside weakness across crypto has focused discussion on forced liquidations and risk-off selling; traders also speculate about rate and tech-market concerns, ETF outflows, and investors freeing up cash for an anticipated IPO. The community is split between calling the drop capitulation and expecting further losses, with some looking for a relief bounce.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 0.92173784 USD and is down -8.73 over the last 24 hours. It is currently trading on 1896 active market(s) with $4,059,642,828.82 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs steep decline alongside a broad crypto selloffoften attributed by traders to Bitcoin weakness and leveraged liquidationsis dominating discussion. The community is split between buyers treating the pullback as a buying opportunity and bears warning that selling pressure could continue; no single XRP-specific catalyst is widely established.

Litecoin (LTC) is a cryptocurrency . Users are able to generate LTC through the process of mining. Litecoin has a current supply of 84,000,000 with 77,830,936.34364598 in circulation. The last known price of Litecoin is 43.58319249 USD and is down -11.87 over the last 24 hours. It is currently trading on 1567 active market(s) with $330,181,316.06 traded over the last 24 hours. More information can be found at https://litecoin.org/.

Litecoin

Litecoins sharp decline and repeated failure to hold rallies are driving discussion, with traders pointing to broader crypto weakness and criticizing LTCs underperformance. Bearish voices warn of further downside after support breaks, while other holders view the selloff as an opportunity to accumulate.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and the possibility of a return as CEO dominate discussion, with traders divided between seeing his leadership as essential and doubting a comeback amid board scrutiny. The debate also centers on U.S. pressure over alleged export-control violations and chip diversion to China, with upcoming earnings facing heightened scrutiny.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZenecas quarterly earnings beat and reaffirmed growth outlook are drawing attention, alongside plans to redirect savings toward R&D and a strategic investment in Summit Therapeutics oncology program. Traders are generally constructive on the pipeline, though some say the market remains hesitant and execution will matter.

statis crypto Watchlist

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$QTOP surely a pricing issue? Up 30%?! $SPY $QQQ